Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 877

The DOI matches its Crossref record.

Modernizing Pharmaceutical Manufacturing: from Batch to Continuous Production

Open access
Lee, Sau L., O’Connor, Thomas F., Yang, Xiaochuan, Cruz, Celia N., Chatterjee, Sharmista, Madurawe, Rapti D., Moore, Christine M. V., Yu, Lawrence X., Woodcock, Janet·2015·Journal of Pharmaceutical Innovation

Abstract

The Food and Drug Administration (FDA) regulates pharmaceutical drug products to ensure a continuous supply of high-quality drugs in the USA. Continuous processing has a great deal of potential to address issues of agility, flexibility, cost, and robustness in the development of pharmaceutical manufacturing processes. Over the past decade, there have been significant advancements in science and engineering to support the implementation of continuous pharmaceutical manufacturing. These investments along with the adoption of the quality-by-design (QbD) paradigm for pharmaceutical development and the advancement of process analytical technology (PAT) for designing, analyzing, and controlling manufacturing have progressed the scientific and regulatory readiness for continuous manufacturing. The FDA supports the implementation of continuous manufacturing using science- and risk-based approaches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12247-015-9215-8

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 28

  1. Myerson AS, Krumme M, Nasr M, Thomas H, Braatz RD. Control systems engineering in continuous pharmaceutical manufacturing May 20–21, 2014 continuous manufacturing symposium. J Pharm Sci. 2014. doi: 10.1002/jps.24311 . · DOI
  2. Felder RM, Rousseau RW. Elementary principles of chemical processes. US: Wiley; 2005.
  3. Allison G, Cain YT, Cooney C, Garcia T, Bizjak TG, Holte O, et al. Regulatory and quality considerations for continuous manufacturing. May 20–21, 2014 continuous manufacturing symposium. J Pharm Sci. 2015. doi: 10.1002/jps.24324 . · DOI · Paper page
  4. Mascia S, Heider PL, Zhang H, Lakerveld R, Benyahia B, Barton PI, et al. End-to-end continuous manufacturing of pharmaceuticals: integrated synthesis, purification, and final dosage formation. Angew Chem Int Ed. 2013;52:12359–63. · DOI · Paper page
  5. Malet-Sanz L, Susanne F. Continuous flow synthesis: a pharma perspective. J Med Chem. 2012;55:4062–98. · DOI · Paper page
  6. Schaber SD, Gerogiorgis DI, Ramachandran R, Evans JM, Barton PI, Trout BL. Economic analysis of integrated continuous and batch pharmaceutical manufacturing: a case study. Ind Eng Chem Res. 2011;50:10083–92. · DOI · Paper page
  7. Poechlauer P, Manley J, Broxterman R, Gregertsen B, Ridemark M. Continuous processing in the manufacture of active pharmaceutical ingredients and finished dosage forms: an industry perspective. Org Proc Res Dev. 2012;16:1586–90. · doi:10.1021/op300159y
  8. Webb D, Jamison TF. Continuous flow multi-step organic synthesis. Chem Sci. 2010;1(6):675–80. · DOI · Paper page
  9. Chen J, Sarma B, Evans JM, Myerson AS. Pharmaceutical crystallization. Crystal Growth Des. 2011;11:887–95. · doi:10.1021/cg101556s
  10. Byrn S, Futran M, Thomas H, Jayjock E, Maron N, Meyer RF, et al. Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20–21, 2014 continuous manufacturing symposium. J Pharm Sci. 2014. doi: 10.1002/jps.24247 . · doi:10.1002/jps.24247
  11. Badman C, Trout BL. Achieving continuous manufacturing. May 20–21, 2014 continuous manufacturing symposium. J Pharm Sci. 2014. doi: 10.1002/jps.24246 . · doi:10.1002/jps.24246
  12. Boukouvala F, Niotis V, Ramachandran R, Muzzio F, Ierapetritou MG. An integrated approach for dynamic flowsheet modeling and sensitivity analysis of a continuous tablet manufacturing process. Comput Chem Eng. 2012;42:30–47. · DOI · Paper page
  13. Benyahia B, Lakerveld R, Barton PI. A plant-wide dynamic model of a continuous pharmaceutical process. Ind Eng Chem Res. 2012;51:15393–412. · doi:10.1021/ie3006319
  14. Lakerveld R, Benyahia B, Braatz RD, Barton PI. Model-based design of a plant-wide control strategy for a continuous pharmaceutical plant. AIChE J. 2013;59:3671–85. · DOI
  15. Kvarnstrom B, Bergquist B. Improving traceability in continuous processes using flow simulations. Prod Plan Control. 2012;23:396–404. · doi:10.1080/09537287.2011.561813
  16. Gao YJ, Vanarase A, Muzzio FJ, Ierapetritou M. Characterizing continuous powder mixing using residence time distribution. Chem Eng Sci. 2011;66:417–25. · DOI
  17. Reitz E, Podhaisky H, Ely D, Thommes M. Residence time modeling of hot melt extrusion processes. Eur J Pharm Biopharm. 2013;85:1200–5. · DOI
  18. Moe T. Perspectives on traceability in food manufacture. Trends Food Sci Tech. 1998;9:211–4. · DOI · Paper page
  19. ICH Q8. ICH Harmonised Tripartite Guideline: Pharmaceutical Development Q8(r2), Current Step 4 Version. Geneva, Switzerland: The International Conference on Harmonisation; 2009.
  20. Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, et al. Understanding pharmaceutical quality by design. AAPS J. 2014;16:771–83. · DOI · Paper page
  21. Singh R, Ierapetritou M, Ramachandran R. System-wide hybrid MPC-PID control of a continuous pharmaceutical tablet manufacturing process via direct compaction. Eur J Pharm Biopharm. 2013;85:1164–82. · doi:10.1016/j.ejpb.2013.02.019
  22. Skoglund T, Dejmek P. Fuzzy traceability: a process simulation derived extension of the traceability concept in continuous food processing. Food Bioprod Process. 2007;85:354–9. · doi:10.1205/fbp07044
  23. Vanarase AU, Jarvinen M, Paaso J, Muzzio FJ. Development of a methodology to estimate error in the on-line measurements of blend uniformity in a continuous powder mixing process. Powder Technol. 2013;241:263–71. · DOI
  24. Wahl PR, Treffer D, Mohr S, Roblegg E, Koscher G, Khinast JG. Inline monitoring and a PAT strategy for pharmaceutical hot melt extrusion. Int J Pharm. 2013;455:159–68. · DOI
  25. Markl D, Wahl PR, Menezes JC, Koller DM, Kavsek B, Francois K, et al. Supervisory control system for monitoring a pharmaceutical hot melt extrusion process. AAPS Pharm Sci Tech. 2013;14:1034–44. · DOI
  26. Schilling EG, Neubauer DV. Acceptance sampling in quality control. Boca Raton: CRC Press; 2009. · doi:10.1201/9781584889533
  27. Kourti T. The process analytical technology initiative and multivariate process analysis, monitoring and control. Anal Bioanal Chem. 2006;384:1043–8. · DOI
  28. Kourti T. Application of latent variable methods to process control and multivariate statistical process control in industry. Int J Adapt Control Signal Process. 2005;19:213–46. · DOI · Paper page

Cited by

See all 877

Metadata

Authors
Lee, S. L., O’Connor, T. F., Yang, X., Cruz, C. N., Chatterjee, S., Madurawe, R. D., Moore, C. M. V., Yu, L. X., & Woodcock, J.
Venue
Journal of Pharmaceutical Innovation
Published
2015-03-19
Volume
10
Issue
3
Pages
191-199
ISSN
  • 1872-5120 (ISSN-L)
  • 1939-8042
OpenAlex
W2073010988
Cited by
877
References
0
FWCI
55.15
Type
journal article
Language
en
Open access
green
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modernizing Pharmaceutical Manufacturing: from Batch to Continuous Production. https://app.cochat.ai/papers/10.1007/s12247-015-9215-8
The paper
Lee, S. L., O’Connor, T. F., Yang, X., Cruz, C. N., Chatterjee, S., Madurawe, R. D., Moore, C. M. V., Yu, L. X., & Woodcock, J. (2015). Modernizing Pharmaceutical Manufacturing: from Batch to Continuous Production. Journal of Pharmaceutical Innovation. https://doi.org/10.1007/s12247-015-9215-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.